Antibody-Drug Conjugate

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

SAN ANTONIO — In this video, Patrick McIntire, MD, discusses findings from the DESTINY-Breast04 and DESTINY-Breast06 trials presented at San Antonio Breast Cancer Symposium.

In this video, Naval Daver, MD, discusses a presentation on updates in immune and cellular therapy in acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

In this video interview, Sara M. Tolaney, MD, MPH, discusses the approvals of antibody-drug conjugates and oral targeted agents that improve outcomes among patients with breast cancer.

In this episode, host Shikha Jain, MD, speaks with Komal Jhaveri, MD, about breakthroughs in breast cancer treatment, where the field is evolving with anti-body drug conjugates and more.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.

Healio spoke with Wendy Chen, MD, MPH about recent advancements in metastatic triple-negative breast cancer.